ARZU BİLEN, NURİNNİSA ÖZTÜRK, Filiz MERCANTEPE, Ramazan DAYANAN, Serpil ÇİFTEL, Enver ÇİFTEL, Habib BİLEN, İlyas ÇAPOĞLU

Levels of obestatin in euthyroid patients receiving levothyroxine replacement therapy

To investigate the relationship between obestatin and TSH levels in patients who received thyroid hormone replacement and were in the euthyroid state. Included 30 patients who were followed up in the endocrinology outpatient clinic in 2020, who received L-thyroxine replacement, and 30 healthy individuals without any chronic disease who did not receive thyroid hormone replacement. Blood samples were taken from both groups for obestatin, thyroid-stimulating hormone (TSH) and free T4 hormone (fT4) levels. There is significant difference in TSH levels (p = 0.007) was found between the two groups. The obestatin levels of the L-thyroxine replacement group were lower than those of the control group (p = 0.001). No correlation was observed between the TSH and obestatin levels in the control and L-thyroxine replacement groups. In this study, obestatin levels were significantly lower in patients who received L-thyroxine replacement therapy and were in euthyroid status than those in the control group. No correlation was found between obestatin and TSH levels in the control and patient groups. As a result of this study, the thyroid gland may play a more important role in the synthesis or regulation of obestatin synthesis beyond our current knowledge.

PDF

___

1. Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656-60.

2. Grönberg M, Tsolakis AV, Magnusson L, et al. Distribution of obestatin and ghrelin in human tissues: immunoreactive cells in the gastrointestinal tract, pancreas, and mammary glands. J Histochem Cytochem. 2008;56:793-801.

3. Zhang JV, Ren PG, Avsian-Kretchmer O, et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science. 2005;310:996-9.

4. Granata R, Gallo D, Luque RM, et al. Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation. Faseb j. 2012;26:3393-411.

5. Qi X, Li L, Yang G, et al. Circulating obestatin levels in normal subjects and in patients with impaired glucose regulation and type 2 diabetes mellitus. Clin Endocrinol (Oxf). 2007;66:593-7.

6. Gurgul E, Kasprzak A, Blaszczyk A, et al. Ghrelin and obestatin in thyroid gland - immunohistochemical expression in nodular goiter, papillary and medullary cancer. Folia Histochem Cyto. 2015;53:19-25.

7. Adsani H, Hoffer LJ, Silva JE. Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid hormone replacement. J Clin Endocrinol Metab. 1997;82:1118-25.

8. Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid. 2014;24:1670-751.

9. Hall KD, Kahan S. Maintenance of lost weight and long-term management of obesity. Medical Clinics. 2018;102:183-97.

10. Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014;94:355-82.

11. Jonklaas J, Nsouli-Maktabi H. Weight changes in euthyroid patients undergoing thyroidectomy. Thyroid. 2011;21:1343-51.

12. Díez JJ, Iglesias P. Relationship between thyrotropin and body mass index in euthyroid subjects. Exp Clin Endocrinol Diabetes. 2011;119(3):144-50.

13. Manji N, Boelaert K, Sheppard MC, et al. Lack of association between serum TSH or free T4 and body mass index in euthyroid subjects. Clin Endocrinol (Oxf). 2006;64:125-8.

14. Toft Kristensen T, Larsen J, Pedersen PL, et al. Weight gain and serum TSH increase within the reference range after hemithyroidectomy indicate lowered thyroid function. J Thyroid Res. 2014;2014:892573.

15. Smitka K, Papezova H, Vondra K, et al. The role of "mixed" orexigenic and anorexigenic signals and autoantibodies reacting with appetite-regulating neuropeptides and peptides of the adipose tissue-gut-brain axis: relevance to food intake and nutritional status in patients with anorexia nervosa and bulimia nervosa. Int J Endocrinol. 2013;2013:483145.

16. Emami A, Nazem R, Hedayati M. Is association between thyroid hormones and gut peptides, ghrelin and obestatin, able to suggest new regulatory relation between the HPT axis and gut? Regul Peptides. 2014;189:17-21.

17. Zhao CM, Furnes MW, Stenström B, et al. Characterization of obestatinand ghrelin-producing cells in the gastrointestinal tract and pancreas of rats: an immunohistochemical and electron-microscopic study. Cell Tissue Res. 2008;331:575-87.

18. Gurgul E, Ruchala M, Kosowicz J, et al. Ghrelin and obestatin in thyroid dysfunction. Endokrynol Pol. 2012;63:456-62.

19. González-Muniesa P, Mártinez-González MA, Hu FB, et al. Obesity. Nat Rev Dis Primers. 2017;3:17034.

20. Aly GS, Hassan NE, Anwar GM, et al. Ghrelin, obestatin and the ghrelin/ obestatin ratio as potential mediators for food intake among obese children: a case control study. J Pediatr Endocrinol Metab. 2020;33:199-204.

21. Razzaghy-Azar M, Nourbakhsh M, Pourmoteabed A, et al. An evaluation of acylated ghrelin and obestatin levels in childhood obesity and their association with insulin resistance, metabolic syndrome, and oxidative stress. J Clin Med. 2016;5.

22. Zhang N, Yuan C, Li Z, et al. Meta-analysis of the relationship between obestatin and ghrelin levels and the ghrelin/obestatin ratio with respect to obesity. Am J Med Sci. 2011;341:48-55.

23. Williams DM, Nawaz A, Evans M. Drug therapy in obesity: a review of current and emerging treatments. Diabetes Ther. 2020;11:1199-216.